Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 3, 2004, Pages 359-371

  Fernandez, Christine ^a,b   Buyse, Marion ^a,b   German Fattal, Michèle ^a,b   Gimenez, François ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN P; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG TRANSPORT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INFLAMMATION; INTESTINE; LIVER; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

ANIMALS; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; P-GLYCOPROTEINS; RATS;

EID: 27444443972     PISSN: 14821826     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Juliano, R. L., and Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta, 455: 152-62, 1976.
2. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. Cellular localization of the multidrug resistance gene product in normal human tissues. Proc Natl Acad Sci U S A, 84: 7735-8, 1987.
3. Dantzig, A. H., de Alwis, D. P., and Burgess, M. Considerations in the design and development of transport inhibitors as adjuncts to drug therapy. Adv Drug Deliv Rev, 55: 133-50, 2003.
4. Sukhai, M., and Piquette-Miller, M. Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci, 3: 268-80, 2000.
5. Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H. P., von Richter, O., Zundler, J., and Kroemer, H. K. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest, 104: 147-53, 1999.
6. Wadler, S., and Schwartz, E. L. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res., 50: 3473-86, 1990.
7. McRae, M. P., Brouwer, K. L. R., and Kashuba, A. D. M. Cytokine regulation of P-glycoprotein. Drug Metab Rev, 35: 19-33, 2003.
8. Smit, J. J., Schinkel, A. H., Oude-Elferink, R. P., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A., Ottenhoff, R., van der Lugt, N. M., van Roon, M. A., Offerhaus, G. J. A., Berns, A. J. M., and Borst, P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 75: 451-62, 1993.
9. Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., and Borst, P. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest, 96: 1698-705, 1995.
10. Barrand, M. A., Robertson, K. J., and von Weikersthal, S. F. Comparisons of P-glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta. FEBS Lett, 374: 179-83, 1995.
11. Lum, B. L., and Gosland, M. P. MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors. Hematol Oncol Clin North Am, 9: 319-36, 1995.
12. Golden, P. L., and Pardridge, W. M. Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain. Cell Mol Neurobiol, 20: 165-81, 2000.
13. Lee, G., Schlichter, L., Bendayan, M., and Bendayan, R. Functional expression of P-glycoprotein in rat brain microglia. J Pharmacol Exp Ther, 299: 204-12, 2001.
14. Rao, V. V., Dahlheimer, J. L., Bardgett, M. E., Snyder, A. Z., Finch, R. A., Sartorelli, A. C., and Piwnica-Worms, D. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci U S A, 96: 3900-5, 1999.
15. Lin, J. H., and Yamazaki, M. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet, 42: 59-98, 2003.
16. van Asperen, J., van Tellingen, O., and Beijnen, J. H. The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice. Drug Metab Dispos., 28: 264-7, 2000.
17. Schinkel, A. H., Wagenaar, E., Mol, C. A., and van Deemter, L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest, 97: 2517-24, 1996.
18. Mayer, U., Wagenaar, E., Beijnen, J. H., Smit, J. W., Meijer, D. K., van Asperen, J., Borst, P., and Schinkel, A. H. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br J Pharmacol, 119: 1038-44, 1996.
19. Schinkel, A. H., Smit, J. J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A., van der Valk, M. A., Robanus-Maandag, E. C., and te Riele, H. P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77: 491-502, 1994.
20. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem, 62: 385-427, 1993.
21. Munoz-Fernandez, M. A., and Fresno, M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Progress Neurobiol, 56: 307-40, 1998.
22. Abdel-Razzak, Z., Loyer, P., Fautrel, A., Gautier, J. C., Corcos, L., Turlin, B., Beaune, P., and Guillouzo, A. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol, 44: 707-15, 1993.
23. Parmentier, J. H., Schohn, H., Bronner, M., Ferrari, L., Batt, A. M., Daucat, M., and Kremers, P. Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1beta, interleukin-6 and dexamethasone in cultured fetal rat hepatocytes. Biochem Pharmacol, 54: 889-98, 1997.
24. Turrin, N. P., Gayle, D., Ilyin, S. E., Flynn, M. C., Langhans, W., Schwartz, G. J., and Plata-Salaman, C. R. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull, 54: 443-53, 2001.
25. De Simoni, M. G., Terreni, L., Chiesa, R., Mangiarotti, F., and Forloni, G. L. Interferon-gamma potentiates interleukin (IL)-6 and tumor necrosis factor-alpha but not IL-1beta induced by endotoxin in the brain. Endocrinology, 138: 5220-6, 1997.
26. Teeter, L. D., Estes, M., Chan, J. Y., Atassi, H., Sell, S., Becker, F. F., and Kuo, M. T. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol Carcinog, 8: 67-73, 1993.
27. Hirsch-Ernst, K. I., Ziemann, C., Foth, H., Kozian, D., Schmitz-Salue, C., and Kahl, G. F. Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture. Biochem Biophys Res Commun, 215: 179-85, 1995.
28. Goralski, K. B., Hartmann, G., Piquette-Miller, M., and Renton, K. W. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol, 139: 35-48, 2003.
29. Ando, H., Nishio, Y., Ito, K., Nakao, A., Wang, L., Zhao, Y. L., Kitaichi, K., Takagi, K., and Hasegawa, T. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob Agents Chemother, 45: 3462-7, 2001.
30. Vos, T. A., Hooiveld, G. J., Koning, H., Childs, S., Meijer, D. K., Moshage, H., Jansen, P. L., and Muller, M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology, 28: 1637-44, 1998.
31. Sukhai, M., Yong, A., Kalitsky, J., and Piquette-Miller, M. Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes. Mol Cell Biol Res Commun, 4: 248-56, 2000.
32. Piquette-Miller, M., Pak, A., Kim, H., Anari, R., and Shahzamani, A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res, 15: 706-11, 1998.
33. Hartmann, G., Kim, H., and Piquette-Miller, M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol, 1: 189-99, 2001.
34. Trauner, M., Arrese, M., Soroka, C. J., Ananthanarayanan, M., Koeppel, T. A., Schlosser, S. F., Suchy, F. J., Keppler, D., and Boyer, J. L. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology, 113: 255-64, 1997.
35. Hirsch-Ernst, K. I., Ziemann, C., Foth, H., Kozian, D., Schmitz-Salue, C., and Kahl, G. F. Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures. J Cell Physiol, 176: 506-15, 1998.
36. Lee, G., and Piquette-Miller, M. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol, 79: 876-84, 2001.
37. Sukhai, M., Yong, A., Pak, A., and Piquette-Miller, M. Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes. Inflamm Res, 50: 362-70, 2001.
38. Akazawa, Y., Kawaguchi, H., Funahashi, M., Watanabe, Y., Yamaoka, K., Hashida, M., and Takakura, Y. Effect of interferons on P-glycoprotein-mediated rhodamine-123 efflux in cultured rat hepatocytes. J Pharm Sci, 91: 2110-5, 2002.
39. Mandi, Y., Ocsovszki, I., Szabo, D., Nagy, Z., Nelson, J., and Molnar, J. Nitric oxide production and MDR expression by human brain endothelial cells. Anticancer Res, 18: 3049-52, 1998.
40. Theron, D., Barraud de Lagerie, S., Tardivel, S., Pelerin, H., Demeuse, P., Mercier, C., Mabondzo, A., Farinotti, R., Lacour, B., Roux, F., and Gimenez, F. Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochem Pharmacol, 66: 579-87, 2003.
41. Zhao, Y. L., Du, J., Kanazawa, H., Cen, X. B., Takagi, K., Kitaichi, K., Tatsumi, Y., Takagi, K., Ohta, M., and Hasegawa, T. Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice. Brain Res, 956: 246-53, 2002.
42. Ramegowda, B., Samuel, J. E., and Tesh, V. L. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J Infect Dis, 180: 1205-13, 1999.
43. Monville, C., Fages, C., Feyens, A. M., D'Hondt, V., Guillet, C., Vernallis, A., Gascan, H., and Peschanski, M. Astroglial expression of the P-glycoprotein is controlled by intracellular CNTF. BMC Cell Biol, 3: 20, 2002.
44. Walther, W., Stein, U., and Pfeil, D. Gene transfer of human TNF alpha into glioblastoma cells permits modulation of mdr1 expression and potentiation of chemosensitivity. Int J Cancer, 61: 832-9, 1995.
45. Bertilsson, P. M., Olsson, P., and Magnusson, K. E. Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells. J Pharm Sci, 90: 638-46, 2001.
46. Stein, U., Walther, W., and Shoemaker, R. H. Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance. Br J Cancer, 74: 1384-91, 1996.
47. Stein, U., Walther, W., and Shoemaker, R. H. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. J Natl Cancer Inst, 88: 1383-92, 1996.
48. Belliard, A. M., Tardivel, S., Farinotti, R., Lacour, B., and Leroy, C. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells. J Pharm Pharmacol, 54: 1103-9, 2002.
49. Bonhomme-Faivre, L., Pelloquin, A., Tardivel, S., Urien, S., Mathieu, M. C., Castagne, V., Lacour, B., and Farinotti, R. Recombinant interleukin-2 treatment decreases P-glycoprotein activity and paclitaxel metabolism in mice. Anticancer Drugs, 13: 51-7, 2002.
50. Veau, C., Faivre, L., Tardivel, S., Soursac, M., Banide, H., Lacour, B., and Farinotti, R. Effect of interleukin-2 on intestinal P-glycoprotein expression and functionality in mice. J Pharmacol Exp Ther, 302: 742-50, 2002.
51. Castagne, V., Bonhomme-Faivre, L., Urien, S., Reguiga, M. B., Soursac, M., Gimenez, F., and Farinotti, R. Effect of recombinant interleukin-2 pre-treatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice. Drug Metab Dispos., 32:168-71, 2004.
52. Akira, S. IL-6-regulated transcription factors. Int J Biochem Cell Biol, 29: 1401-18, 1997.
53. Conze, D., Weiss, L., Regen, P. S., Bhushan, A., Weaver, D., Johnson, P., and Rincon, M. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res, 61: 8851-8, 2001.
54. Chen, G. K., Sale, S., Tan, T., Ermoian, R. P., and Sikic, B. I. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells. Mol Pharmacol, 65: 906-16, 2004.
55. Combates, N. J., Rzepka, R. W., Chen, Y. N., and Cohen, D. NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. J Biol Chem, 269: 29715-9, 1994.
56. Ros, J. E., Schuetz, J. D., Geuken, M., Streetz, K., Moshage, H., Kuipers, F., Manns, M. P., Jansen, P. L., Trautwein, C., and Muller, M. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling. Hepatology, 33: 1425-31, 2001.
57. Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M. P., and Bours, V. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 22: 90-7, 2003.
58. Manara, M. C., Serra, M., Benini, S., Picci, P., and Scotlandi, K. Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma. cells. Int J Oncol, 24: 365-72, 2004.
59. Quattrochi, L. C., and Guzelian, P. S. Cyp3A regulation: from pharmacology to nuclear receptors. Drug Metab Dispos., 29: 615-22, 2001.
60. Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterstrom, R. H., Perlmann, T., and Lehmann, J. M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell, 92: 73-82, 1998.
61. Savas, U., Wester, M. R., Griffin, K. J., and Johnson, E. F. Rabbit pregnane X receptor is activated by rifampicin. Drug Metab Dispos., 28: 529-37, 2000.
62. Zhang, H., LeCulyse, E., Liu, L., Hu, M., Matoney, L., Zhu, W., and Yan, B. Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys, 368: 14-22, 1999.
63. Bertilsson, G., Heidrich, J., Svensson, K., Asman, M., Jendeberg, L., Sydow-Backman, M., Ohlsson, R., Postlind, H., Blomquist, P., and Berkenstam, A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A, 95: 12208-13, 1998.
64. Ekins, S., and Erickson, J. A. A pharmacophore for human pregnane X receptor ligands. Drug Metab Dispos., 30: 96-9, 2002.
65. Synold, T. W., Dussault, I., and Forman, B. M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med, 7: 584-90, 2001.
66. Geick, A., Eichelbaum, M., and Burk, O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem, 276: 14581-7, 2001.
67. Bauer, B., Hartz, A. M., Fricker, G., and Miller, D. S. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol, 66: 413-9, 2004.
68. Pascussi, J. M., Gerbal-Chaloin, S., Pichard-Garcia, L., Daujat, M., Fabre, J. M., Maurel, P., and Vilarem, M. J. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun, 274: 707-13, 2000.